NEU 0.00% $17.09 neuren pharmaceuticals limited

The ongoing improvement at cessation of treatment at day 54...

  1. 1,300 Posts.
    lightbulb Created with Sketch. 6
    The ongoing improvement at cessation of treatment at day 54 shows potential for further benefit hopefully compassionate use will be available next, to allow Retts patients and their family's the benefit of this significant and apparently sustained improvement
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.